Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
75.33
-0.82 (-1.08%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 74.87 - 75.89
52 week 54.90 - 78.33
Open 75.46
Vol / Avg. 1.58M/1.64M
Mkt cap 10.87B
P/E 19.90
Div/yield 0.38/2.02
EPS 3.79
Shares 144.31M
Beta 0.64
Inst. own 101%
May 15, 2015
Quest Diagnostics Inc Annual Shareholders Meeting - 10:30AM EDT - Add to calendar
Apr 23, 2015
Q1 2015 Quest Diagnostics Inc Earnings Release - 9:30AM EDT - Add to calendar
Apr 23, 2015
Q1 2015 Quest Diagnostics Inc Earnings Call - 8:30AM EDT - Add to calendar
Mar 31, 2015
Quintiles Transnational Holdings Inc and Quest Diagnostics to Form Joint Venture to Provide Global Clinical Trials Laboratory Services Call
Mar 11, 2015
Quest Diagnostics Inc at Barclays Healthcare Conference - Webcast
Jan 29, 2015
Q4 2014 Quest Diagnostics Inc Earnings Release
Jan 29, 2015
Q4 2014 Quest Diagnostics Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 10.36% 7.90%
Operating margin 13.65% 13.22%
EBITD margin - 18.04%
Return on average assets 7.78% 6.24%
Return on average equity 17.12% 13.31%
Employees 45,000 -
CDP Score - 83 C

Address

3 Giralda Farms
MADISON, NJ 07940
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. The Company�s operations are organized in two business groups, such as diagnostics information services and diagnostic solutions. Its diagnostics information services business is the provider of clinical testing services, gene-based, esoteric and anatomic pathology testing services and forensic drugs-of-abuse testing services. Its diagnostic solutions include Healthcare information technology, clinical trials testing, life insurer services and diagnostic products. The Company�s diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. It offers a range of solutions, including urine, hair, blood and oral fluid tests.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 53
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 53
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Chief Medical Officer
Age: 60
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 48
Bio & Compensation  - Reuters
James E. Davis Senior Vice President - Operations
Age: 52
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President - Clinical Franchises
Age: 52
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Vicky B. Gregg Director
Age: 59
Bio & Compensation  - Reuters
John C. Baldwin M.D. Independent Director
Age: 65
Bio & Compensation  - Reuters